Join
Live feed
·
INSIDERFilingvia Quantisnow
Kronos Bio Inc. logo

President & Interim CEO Knobelman Deborah sold $21,554 worth of shares (24,838 units at $0.87), decreasing direct ownership by 15% to 139,422 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KRON· Kronos Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRON (Kronos Bio Inc.) and more on Quantisnow.